1. Alectos Therapeutics Inc. (15 from 18 patents)

2. Merck Sharp + Dohme Corp. (14 from 2,405 patents)

3. Anormed, Inc. (13 from 40 patents)

4. Genzyme Corporation (9 from 787 patents)

5. Simon Fraser University (4 from 155 patents)

6. Other (1 from 832,680 patents)

1. 10913733 - Substituted piperidines thiazolyl acetamides as glycosidase inhibitors and uses thereof

2. 10322111 - Chemokine receptor binding heterocyclic compounds with enhanced efficacy

3. 10081601 - Glucocerebrosidase modulators and uses thereof

4. 9938299 - Glycosidase inhibitors and uses thereof

5. 9815861 - Selective glycosidase inhibitors and uses thereof

6. 9809537 - Glycosidase inhibitors and uses thereof

7. 9796680 - Glucocerebrosidase modulators and uses thereof

8. 9718854 - Selective glycosidase inhibitors and uses thereof

9. 9695197 - Glycosidase inhibitors and uses thereof

10. 9670195 - Glycosidase inhibitors and uses thereof

11. 9611275 - Permeable glycosidase inhibitors and uses thereof

12. 9522883 - Glycosidase inhibitors and uses thereof

13. 9409924 - Selective glycosidase inhibitors and uses thereof

14. 9243020 - Selective glycosidase inhibitors and uses thereof

15. 9199949 - Selective glycosidase inhibitors and uses thereof